We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 21st:
Bio-Rad Laboratories, Inc. (BIO - Free Report) : This manufacturer of products and solutions for life science research has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
DENTSPLY SIRONA Inc. (XRAY - Free Report) : This dental and oral health products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
Lantheus Holdings, Inc. : This diagnostic medical imaging agents and products manufacturer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.
Masimo Corporation (MASI - Free Report) : This medical technology company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 21st
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 21st:
Bio-Rad Laboratories, Inc. (BIO - Free Report) : This manufacturer of products and solutions for life science research has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
Bio-Rad Laboratories, Inc. Price and Consensus
Bio-Rad Laboratories, Inc. price-consensus-chart | Bio-Rad Laboratories, Inc. Quote
Bio-Rad Laboratories’ shares gained 13.3% over the last one month against the S&P 500’s rise of 1.8%. The company possesses a Momentum Score of B.
Bio-Rad Laboratories, Inc. Price
Bio-Rad Laboratories, Inc. price | Bio-Rad Laboratories, Inc. Quote
DENTSPLY SIRONA Inc. (XRAY - Free Report) : This dental and oral health products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.5% over the last 60 days.
DENTSPLY SIRONA Inc. Price and Consensus
DENTSPLY SIRONA Inc. price-consensus-chart | DENTSPLY SIRONA Inc. Quote
DENTSPLY SIRONA’s shares gained 17.4% over the last one month. The company possesses a Momentum Score of A.
DENTSPLY SIRONA Inc. Price
DENTSPLY SIRONA Inc. price | DENTSPLY SIRONA Inc. Quote
Lantheus Holdings, Inc. : This diagnostic medical imaging agents and products manufacturer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.
Lantheus Holdings, Inc. Price and Consensus
Lantheus Holdings, Inc. price-consensus-chart | Lantheus Holdings, Inc. Quote
Lantheus’ shares gained 16.4% over the last one month. The company possesses a Momentum Score of A.
Lantheus Holdings, Inc. Price
Lantheus Holdings, Inc. price | Lantheus Holdings, Inc. Quote
Masimo Corporation (MASI - Free Report) : This medical technology company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
Masimo Corporation Price and Consensus
Masimo Corporation price-consensus-chart | Masimo Corporation Quote
Masimo’s shares gained 3.7% over the last one month. The company possesses a Momentum Score of A.
Masimo Corporation Price
Masimo Corporation price | Masimo Corporation Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
See Stocks Today >>